Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Current-Deferred-Revenue" stands at 3.88 Billion United States Dollars as of 09/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 96.15 percent compared to the value the year prior.
The 1 year change in percent is 96.15.
The 3 year change in percent is -52.85.
The 5 year change in percent is -37.05.
The 10 year change in percent is -7.15.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Current Deferred Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Current Deferred Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Current Deferred Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Current Deferred Revenue | 280,205,508,085.11 |
![]() | Novartis AG - Current Deferred Revenue | 255,096,620,580.91 |